These results suggested that TB might attenuate obesity-induced inflammation and mitochondrial dysfunction by modulating adipose tissue inflammation and the muscle PGC-1α/SIRT1 pathway. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.